Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation
Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […] The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.
Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation.
The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.